Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004952 · ClinicalTrials.gov registry record
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 94
- Enrollment target
NCT01004952: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01004952 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01004952 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so that they can improve their ability to help individuals who may be at risk for melanoma.
Primary Outcome
To generate models explaining decision-making about four UVR protection behaviors (sunscreen use, shade-seeking, hat use, use of protective clothing) in melanoma FDRs. This was an inductive, qualitative study using an open-ended interview to accomplish the Aim. Cohort 1 was used for this Aim.
Interventions
- BEHAVIORAL screening questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2009-10-27 |
| Est. Completion | 2024-09-06 |
What the finished NCT01004952 record still lists
NCT01004952 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which screening questionnaire is the first listed.
NCT01004952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01004952 about?
NCT01004952 is a clinical study titled "Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection". The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so tha...
What is the current status of trial NCT01004952?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2009-10-27. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT01004952?
The interventions under investigation include: screening questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT01004952?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI